CytoChip is showcasing its flagship product, CitoCBC, the first cartridge-based Complete Blood Count (CBC) analyzer to receive both FDA 510(k) clearance and CLIA Waiver, at the Association for Diagnostics & Laboratory Medicine (ADLM) 2025 conference.
CitoCBC delivers rapid, lab-quality CBC results with a 5-part white blood cell differential, all from a cartridge-based system designed for ease of use. Requiring only monthly quality control, it offers an ideal solution for healthcare providers looking to expand their CLIA-waived testing capabilities with CBC.
Following ADLM, product deliveries for existing CitoCBC orders will commence, with broader availability supported by a partnership with a leading national distributor serving the U.S. physician office market.
CytoChip will also debut CitoPRP, an innovative solution for analyzing platelet-rich plasma (PRP). The CitoPRP system uses a disposable cartridge to accurately measure platelet concentrations up to 4 billion cells/mL, eliminating the need for manual dilution and minimizing the risk of analyzer clogging.
Attendees are invited to visit CytoChip at Booth #1363 during the ADLM Clinical Lab Expo to explore these new technologies and meet the team. Healthcare providers and distribution partners interested in learning more can connect directly at the booth.
Visit CytoChip for more news
